🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Achieving #vaccineequity: challenges & opportunities of multi-modality manufacturing Next-generation #vaccine platforms comprise different modalities, including #viralvectors (e.g., AAV), #pDNA, and #mRNA. Read this #article below: insights.bio/vaccine-insigh…

#Proteincharacterization using variable pathlength #spectroscopy: high- & low-concentration methods This #article describes the use of variable pathlength technology for #proteinconcentration measurement Read below: buff.ly/3SxidVZ

Achieving #vaccineequity: challenges & opportunities of multi-modality manufacturing This #article explores the manufacturing processes of next-generation #vaccineplatforms (e.g., #mRNA and #viralvectors) Read below: buff.ly/4bEyOzW

#Proteincharacterization using #variablepathlengthspectroscopy: high- & low-concentration methods This #article describes the use of variable pathlength technology for protein concentration measurement Read below: buff.ly/49ZklwK

#Affinitychromatography for #malaria #vaccinepurification This #poster presents a case study showing how researchers used #Ctagtechnology to capture a candidate #malariavaccine. View below: buff.ly/3TaYLi8

The COVID-19 pandemic has emphasized the need for readily available commercial-scale vaccine production tools to support global immunization efforts. Here, novel tools and potential strategies for future vaccine development are explored Read below: buff.ly/4cI5o4p

My colleague Jeanette Hayes and I share our thoughts on the challenges of vaccine manufacturing - using cholera as an example 👇 cdn.insights.bio/uploads/attach… Vaccine Insights Wellcome

A call for further research: vaccine hesitancy that erupted when mRNA vaccines entered the public consciousness in 2020 to protect against COVID-19, combined with the emergency authorization to allow access to new vaccines... ms.spr.ly/6016YvR4Q

#Vaccinesecurity and self-reliance in South East Asia The new UK-South East Asia #VaccineManufacturing Research Hub will support South East Asia to become a global leader in vaccine production by addressing key priorities Read below: buff.ly/3yhtd3N

This #infographic offers a step-by-step overview of manufacturing and analytical methods for four key #vaccine types: #VLP (virus-like-particle), subunit, #mRNA, and #viralvectorvaccines View below: buff.ly/4c5uWqD

#RSVvaccines: a new hope but the virus might strike back In this #review, an overview of the #antibodies and the vaccines is given Read below: buff.ly/4fpuDtI

How can investing in technology transfers help build a sustainable manufacturing ecosystem? An example from #cholera Read this #viewpoint for insight into the #cholerapandemic and what action is being taken on it. Access below: buff.ly/4d8nuw5

#FastFacts now available! Accelerate #vaccine development with novel #affinitypurification solutions This FastFacts explores the advantages of #affinitychromatography in streamlining the #vaccinepurification bioprocesses Access below: buff.ly/4dxH05b

Impact of #glycosylation of #vaccineantigens on quality and performance Read this expert insight to learn more about #vaccine antigen glycosylation Access below: buff.ly/4dvTZUK

Swiss regulatory aspects and evaluation considerations for #ATMPs and other nucleic acid-based products such as #mRNA-based vaccines Read below: buff.ly/3AFuVg9

Optimized and scalable #LNP composition for #RNAvaccinedelivery This #webinar will introduce a novel ionizable lipid for the delivery of RNA in #vaccine applications Register below: buff.ly/4cPZwov

Evolution of #mRNA-based vaccines: a regulator’s view In this #inteview, pandemic preparedness, the regulatory pathway for mRNA-based vaccines, and the opportunities and challenges posed by their rapid evolution are discussed Read below: buff.ly/3TeVVth

#Viewpoint now available! Best practices and considerations for outsourcing with #CDMOs This #article covers recent trends in the #genetherapy CDMO sector and what these mean for the industry as a whole. Read below: buff.ly/3XsFQTn

This infographic offers a step-by-step overview of manufacturing and analytical methods for four key #vaccine types: #VLP (virus-like-particle), subunit, #mRNA, and #viralvectorvaccines View below: buff.ly/4c5uWqD

Accelerate #vaccine development with novel #affinitypurification solutions This #FastFacts explores the advantages of #affinitychromatography in streamlining the #vaccinepurification bioprocesses Access below: buff.ly/4dxH05b